Stock Track | Ardelyx Shares Soar 6.92% Pre-market on Impressive Q4 Earnings Beat

Stock Track
20 Feb

Ardelyx Inc. (ARDX) shares surged 6.92% in the pre-market trading session on Thursday, following the company's impressive fourth-quarter 2024 earnings results that surpassed analyst estimates.

The biopharmaceutical company reported quarterly earnings of $0.02 per share, beating the consensus estimate of $0.01 by 100%. This marked a significant improvement from the loss of $0.12 per share reported in the same period last year. Ardelyx's revenue for the quarter stood at $116.13 million, a remarkable 237.95% year-over-year increase, and also exceeded the analyst consensus estimate of $109.94 million by 5.63%.

The strong financial performance and better-than-expected results suggest that Ardelyx's products and pipeline are gaining traction, driving investor optimism and propelling the stock higher in the pre-market trading session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10